PA
RPTP

Perceptive Advisors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Perceptive Advisors’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-264,204
Closed -$4.17M – 211
2015
Q2 		$4.17M Buy
264,204
+4
+0% +$49 0.25% 75
2015
Q1 		$2.87M Buy
+264,200
New +$2.7M 0.22% 75

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors's RPTP Position: Q3 2015 in Review

Perceptive Advisors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 264,204 shares — an estimated $4.17M sold.

Perceptive Advisors first reported a position in RPTP in Q1 2015 and held it in 2 quarters. The position peaked at $4.17M in Q2 2015. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

  • Perceptive Advisors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Perceptive Advisors sold 264,204 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $4.17M.
  • Perceptive Advisors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2015 and held it in 2 quarters.
  • Perceptive Advisors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $4.17M in Q2 2015.
  • 106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.